nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System
|
Golomb, Beatrice A. |
|
2018 |
41 |
4 |
p. 403-413 |
artikel |
2 |
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
|
Verden, Abril |
|
2017 |
41 |
4 |
p. 357-361 |
artikel |
3 |
An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study
|
Arnaud, Mickael |
|
2017 |
41 |
4 |
p. 377-387 |
artikel |
4 |
Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study
|
Bergman, Jorieke E. H. |
|
2017 |
41 |
4 |
p. 415-427 |
artikel |
5 |
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials
|
Thai-Cuarto, Dao |
|
2017 |
41 |
4 |
p. 429-440 |
artikel |
6 |
Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
|
Mayer, Lori |
|
2017 |
41 |
4 |
p. 347-356 |
artikel |
7 |
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
|
Cheng, Ning |
|
2017 |
41 |
4 |
p. 363-376 |
artikel |
8 |
Safety of Human Papillomavirus Vaccines: An Updated Review
|
Phillips, Anastasia |
|
2017 |
41 |
4 |
p. 329-346 |
artikel |
9 |
The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products
|
Smith, Meredith Y. |
|
2017 |
41 |
4 |
p. 389-401 |
artikel |
10 |
The Safety of Generic Prescription Drugs in the United States
|
Singh, Sonal |
|
2018 |
41 |
4 |
p. 325-328 |
artikel |